Eng Укр
Eng Укр
Who are we What we do Industries Resources Career Contact us
Cookies help us improve your experience. We use cookies to improve website functionality and performance throughout upharma-c.com. Click "accept all cookies” to continue browsing the site with its full range of features enabled.

Insights & Publications

Executive Search and Recruiting of top and middle management personnel. We are open for a constructive dialogue and are higly focused on the clients' and candidates' needs.
Pharmaceuticals
UPharma Consulting is a professional corporate consultancy focused on Health Care, Pharma & MedTech sectors.
MedTech
CUPharma Consulting is a professional corporate consultancy focused on Health Care, Pharma & MedTech sectorss.
Country reports
CUPharma Consulting is a professional corporate consultancy focused on Health Care, Pharma & MedTech sectorss.

Аdvising companies in their Road-to-Market Pathway

We advise Pharma and MedTech companies on issues arising during their market entry planning stages onwards to the process of local team forming performance monitoring through reports and insights.
Planning & Assessment
Target market opportunity assessment
Therapeutic area and core markets analyses
Competitors & consumers profiling
Marketing Authorization
Product reprocessingration routes
Early market access options
Authorities mapping
Timeline and budgeting for market entry
Price Reprocessingration
Price reprocessingration requirements
Documents needed
Procedure and timelining
>
National FormularyListing
Assessing local formulary listing requirements
KOLs and HCPs mapping
Process schemes and timelines
National Formulary Listing
Assessing local formulary listing requirements
KOLs and HCPs mapping
Process schemes and timelines

Regional Market Trends

Consumption acceleration driven by increasing diagnostic level, patients’ coverage, income growth and economic recovery, innovative therapies consumption increase.
Government budgets expansion in two directions: selected therapies budget increase (oncology, cardio etc.) and additional budget sources (e.g. compulsory health insurance in Kazakhstan, Azerbaijan, Uzbekistan).
Regulatory changes: ongoing healthcare reform in Ukraine, industry de-shadowing policies and tender process in Uzbekistan etc.
Pricing pressure: tight prices controls in Kazakhstan, Uzbekistan, and Azerbaijan, growing generics substitution.
Low penetration of medical services / diagnostic level (low educational level of physicians, diagnostic level for special diseases etc.
Local government initiatives / promotional restrictions: f2f visits restriction in Central Asia, prescription controls in Uzbekistan, official parallel import in Ukraine and Georgia.
Name Name Name Name Name Name Name Name
Central Asia
 RUSSIA 144.4 19.720 136.6 66.946
38
62
 yes strict
UZBEKISTAN 33.6 1.058 31.5 12.994
15
85
 yes mid
KAZAKHSTAN 33.6 1.058 31.5 12.994
37
63
 yes strict
TAJIKISTAN 33.6 1.058 31.5 12.994
12
88
 yes mid
KYRGYZSTAN 33.6 1.058 31.5 12.994
18
82
 yes mid
MONGOLIA 33.6 1.058 31.5 12.994
40
60
 yes slight
Sub-Region 215.5 22.529 51.8 96.519
27
73
Name Name Name Name Name Name Name Name
Central Asia
 RUSSIA 144.4 19.720 136.6 66.946
38
62
 yes strict
UZBEKISTAN 33.6 1.058 31.5 12.994
15
85
 yes mid
KAZAKHSTAN 33.6 1.058 31.5 12.994
37
63
 yes strict
TAJIKISTAN 33.6 1.058 31.5 12.994
12
88
 yes mid
KYRGYZSTAN 33.6 1.058 31.5 12.994
18
82
 yes mid
MONGOLIA 33.6 1.058 31.5 12.994
40
60
 yes slight
Sub-Region 215.5 22.529 51.8 96.519
27
73
Name Name Name Name Name Name Name Name
Central Asia
 RUSSIA 144.4 19.720 136.6 66.946
38
62
 yes strict
UZBEKISTAN 33.6 1.058 31.5 12.994
15
85
 yes mid
KAZAKHSTAN 33.6 1.058 31.5 12.994
37
63
 yes strict
TAJIKISTAN 33.6 1.058 31.5 12.994
12
88
 yes mid
KYRGYZSTAN 33.6 1.058 31.5 12.994
18
82
 yes mid
MONGOLIA 33.6 1.058 31.5 12.994
40
60
 yes slight
Sub-Region 215.5 22.529 51.8 96.519
27
73
Name Name Name Name Name Name Name Name
Central Asia
 RUSSIA 144.4 19.720 136.6 66.946
38
62
 yes strict
UZBEKISTAN 33.6 1.058 31.5 12.994
15
85
 yes mid
KAZAKHSTAN 33.6 1.058 31.5 12.994
37
63
 yes strict
TAJIKISTAN 33.6 1.058 31.5 12.994
12
88
 yes mid
KYRGYZSTAN 33.6 1.058 31.5 12.994
18
82
 yes mid
MONGOLIA 33.6 1.058 31.5 12.994
40
60
 yes slight
Sub-Region 215.5 22.529 51.8 96.519
27
73
Name Name Name Name Name Name Name Name
Central Asia
 RUSSIA 144.4 19.720 136.6 66.946
38
62
 yes strict
UZBEKISTAN 33.6 1.058 31.5 12.994
15
85
 yes mid
KAZAKHSTAN 33.6 1.058 31.5 12.994
37
63
 yes strict
TAJIKISTAN 33.6 1.058 31.5 12.994
12
88
 yes mid
KYRGYZSTAN 33.6 1.058 31.5 12.994
18
82
 yes mid
MONGOLIA 33.6 1.058 31.5 12.994
40
60
 yes slight
Sub-Region 215.5 22.529 51.8 96.519
27
73
Name Name Name Name Name Name Name Name
Central Asia
 RUSSIA 144.4 19.720 136.6 66.946
38
62
 yes strict
UZBEKISTAN 33.6 1.058 31.5 12.994
15
85
 yes mid
KAZAKHSTAN 33.6 1.058 31.5 12.994
37
63
 yes strict
TAJIKISTAN 33.6 1.058 31.5 12.994
12
88
 yes mid
KYRGYZSTAN 33.6 1.058 31.5 12.994
18
82
 yes mid
MONGOLIA 33.6 1.058 31.5 12.994
40
60
 yes slight
Sub-Region 215.5 22.529 51.8 96.519
27
73
Name Name Name Name Name Name Name Name
Central Asia
 RUSSIA 144.4 19.720 136.6 66.946
38
62
 yes strict
UZBEKISTAN 33.6 1.058 31.5 12.994
15
85
 yes mid
KAZAKHSTAN 33.6 1.058 31.5 12.994
37
63
 yes strict
TAJIKISTAN 33.6 1.058 31.5 12.994
12
88
 yes mid
KYRGYZSTAN 33.6 1.058 31.5 12.994
18
82
 yes mid
MONGOLIA 33.6 1.058 31.5 12.994
40
60
 yes slight
Sub-Region 215.5 22.529 51.8 96.519
27
73
Name Name Name Name Name Name Name Name
Central Asia
 RUSSIA 144.4 19.720 136.6 66.946
38
62
 yes strict
UZBEKISTAN 33.6 1.058 31.5 12.994
15
85
 yes mid
KAZAKHSTAN 33.6 1.058 31.5 12.994
37
63
 yes strict
TAJIKISTAN 33.6 1.058 31.5 12.994
12
88
 yes mid
KYRGYZSTAN 33.6 1.058 31.5 12.994
18
82
 yes mid
MONGOLIA 33.6 1.058 31.5 12.994
40
60
 yes slight
Sub-Region 215.5 22.529 51.8 96.519
27
73

Market Access & Assessment

Market Analyses
Opportunity Assessment Core Market Analysis & Forecasting Competitive Environment Audit Competitors & Customers Profiling
Market Access
MA Strategy Development Market Entry Preparation Public Purchases & Tendering Process Regulatory Environment Audit Pricing & Reimbursement
Stakehoider Mapping
Local Payor Research Stakeholders & Infrastructure Mapping Portraying Patients Expert Interviews
Product Launch
Launch Strategy & Planning Promotional Activities Budgeting Launch Tracking Supply Chain Effectiveness Analysis

Practice Leaders

Eugene BROVKO
Partner, Pharma & MedTech Market Access
RFP
Send us your Request For Proposal
file name

Download
our E-Brochure